Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Aspira Pathlab & Diagnostics has informed that Priya Pandey (Membership No. A66213), Company Secretary (CS) and Compliance (CO), Key Managerial Personnel (KMP) of the Company, vide her letter dated June 24, 2023, has tendered her resignation from the services of the Company. She shall be relieved of her duties with effect from the close of business hours of Saturday, June 24, 2023. The Company places on record the valuable contribution and guidance provided by Priya Pandey, during her tenure as Company Secretary and Compliance Officer of the Company. The Company is in the process of appointing a successor for the position of Company Secretary and Compliance Officer, which shall be duly intimated to the Stock Exchange in due course. The details as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 are enclosed as Annexure A. This intimation will also be available on the website of the Company www.aspiradiagnostics.com.
The above information is a part of company’s filings submitted to BSE.
